A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension

NCT02003534 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

376

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma, Open-Angle
Ocular Hypertension

Interventions

DRUG: 0.15% Brimonidine Tartrate

Sponsor

Allergan